Over the past 12 months, 5 insiders at ALX ONCOLOGY HOLDINGS INC filed 11 open-market SEC Form 4 transactions on ALXO: 4 purchases worth $5.2M and 7 sales worth $39K. Insiders have been net sellers over this period. The most recent filing was on Jul 1, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 26 | Shelly WongSVP, FINANCE AND CAO | SELL | 1.4K | $2.04 | $3K |
| Mar 19, 26 | Jason LettmannCHIEF EXECUTIVE OFFICER | SELL | 12.3K | $2.17 | $27K |
| Mar 19, 26 | Shelly PintoSVP, FINANCE AND CAO | SELL | 903 | $2.17 | $2K |
| Feb 18, 26 | Shelly PintoSVP, FINANCE AND CAO | SELL | 565 | $2.27 | $1K |
| Feb 2, 26 | Corey S GoodmanDirector,TenPercentOwner | BUY | 3.18M | $1.57 | $5.0M |
| Jan 6, 26 | Shelly PintoSVP, FINANCE AND CAO | SELL | 3.9K | $1.11 | $4K |
| Sep 17, 25 | Jason LettmannCHIEF EXECUTIVE OFFICER | BUY | 71.2K | $1.08 | $77K |
| Sep 16, 25 | Jason LettmannCHIEF EXECUTIVE OFFICER | BUY | 21.1K | $1.07 | $23K |
| Aug 18, 25 | Harish ShantharamChief Financial Officer | BUY | 75.0K | $0.78 | $59K |
| Aug 15, 25 | Jason LettmannCHIEF EXECUTIVE OFFICER | SELL | 2.4K | $0.64 | $2K |
| Aug 15, 25 | Shelly PintoSVP, FINANCE AND CAO | SELL | 611 | $0.64 | $391 |
| Jul 7, 25 | Shelly PintoSVP, FINANCE AND CAO | SELL | 2.0K | $0.45 | $905 |
| Jun 30, 25 | Shelly PintoSVP, FINANCE AND CAO | SELL | 1.5K | $0.43 | $659 |
| Feb 19, 25 | Jason LettmannCHIEF EXECUTIVE OFFICER | SELL | 2.2K | $1.15 | $2K |
| Feb 19, 25 | Shelly PintoSVP, FINANCE AND CAO | SELL | 550 | $1.15 | $633 |
| Feb 19, 25 | Jaume PonsPRESIDENT & CSO | SELL | 1.3K | $1.15 | $2K |
| Jan 6, 25 | Shelly PintoInterim CFO | SELL | 2.2K | $1.80 | $4K |
| Dec 30, 24 | Shelly PintoInterim CFO | SELL | 1.4K | $1.58 | $2K |
| Dec 30, 24 | Jaume PonsPRESIDENT & CSO | SELL | 10.8K | $1.58 | $17K |
| Dec 2, 24 | Rekha HemrajaniDirector | BUY | 30.0K | $1.55 | $47K |
| Aug 14, 24 | Shelly PintoSVP, FINANCE AND CAO | SELL | 564 | $2.58 | $1K |
| Aug 14, 24 | Jaume PonsPRESIDENT & CSO | SELL | 1.9K | $2.58 | $5K |
| Aug 14, 24 | Sophia RandolphCHIEF MEDICAL OFFICER | SELL | 1.4K | $2.58 | $4K |
| Jul 11, 24 | Jaume PonsPRESIDENT & CSO | SELL | 20.0K | $7.90 | $158K |
| Jul 5, 24 | Shelly PintoSVP, FINANCE AND CAO | SELL | 1.8K | $5.50 | $10K |
| Jul 1, 24 | Shelly PintoSVP, FINANCE AND CAO | SELL | 1.4K | $5.82 | $8K |
| Jul 1, 24 | Jaume PonsPRESIDENT & CSO | SELL | 10.8K | $5.82 | $63K |
| Jul 1, 24 | Sophia RandolphCHIEF MEDICAL OFFICER | SELL | 3.3K | $5.82 | $19K |
| Jun 13, 24 | Peter S GarciaCHIEF FINANCIAL OFFICER | BUY | 12.0K | $8.53 | $102K |
| Jun 4, 24 | Jaume PonsPRESIDENT & CSO | SELL | 20.0K | $8.43 | $169K |
| May 13, 24 | Sophia RandolphCHIEF MEDICAL OFFICER | SELL | 10.2K | $16.67 | $161K |
| May 6, 24 | Jaume PonsPRESIDENT & CSO | SELL | 20.0K | $15.92 | $318K |
| Apr 16, 24 | Jaume PonsPRESIDENT & CSO | SELL | 50.0K | $14.20 | $710K |
| Apr 4, 24 | Jaume PonsPRESIDENT & CSO | SELL | 20.0K | $11.15 | $223K |
| Mar 14, 24 | Jason LettmannCHIEF EXECUTIVE OFFICER | BUY | 4.4K | $11.31 | $50K |
| Jan 4, 24 | Shelly PintoSVP, Finance and CAO | SELL | 2.7K | $13.60 | $37K |
| Dec 29, 23 | Peter S GarciaChief Financial Officer | SELL | 1.9K | $15.04 | $28K |
| Dec 29, 23 | Shelly PintoSVP, Finance and CAO | SELL | 1.6K | $15.04 | $25K |
| Dec 29, 23 | Jaume PonsPresident & CSO | SELL | 7.2K | $15.04 | $108K |
| Dec 29, 23 | Sophia RandolphChief Medical Officer | SELL | 3.1K | $15.04 | $47K |
| Jul 6, 23 | Shelly PintoVP, Finance and CAO | SELL | 7.3K | $6.52 | $48K |
| Jun 30, 23 | Peter S GarciaChief Financial Officer | SELL | 887 | $7.34 | $7K |
| Jun 30, 23 | Shelly PintoVP, Finance and CAO | SELL | 466 | $7.34 | $3K |
| Jun 30, 23 | Jaume PonsPresident & CEO | SELL | 3.2K | $7.34 | $24K |
| Jun 30, 23 | Sophia RandolphChief Medical Officer | SELL | 1.6K | $7.34 | $12K |
| Dec 29, 22 | Peter S GarciaChief Financial Officer | SELL | 893 | $11.07 | $10K |
| Dec 29, 22 | Shelly PintoVP, Finance and CAO | SELL | 482 | $11.07 | $5K |
| Dec 29, 22 | Jaume PonsPresident & CEO | SELL | 3.2K | $11.07 | $36K |
| Dec 29, 22 | Sophia RandolphChief Medical Officer | SELL | 1.6K | $11.07 | $18K |
| Dec 13, 21 | UnknownDirector,TenPercentOwner | SELL | 286.5K | $30.23 | $7.9M |
Over the past 12 months, insiders at ALX ONCOLOGY HOLDINGS INC filed 4 open-market purchases worth $5.2M and 7 sales worth $39K on ALXO, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 1, 26.
The largest recent open-market ALXO insider purchase in our data was $5.0M by Corey S Goodman, Director,TenPercentOwner, filed on Feb 2, 26.
5 different insiders at ALX ONCOLOGY HOLDINGS INC filed open-market SEC Form 4 transactions on ALXO over the last 12 months.
InsiderTape plots every ALXO insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every ALX ONCOLOGY HOLDINGS INC insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →